Post COVID glaucoma service redesign utilising electronic patient triage and community optometry clinics (Fife, Scotland 2020-2022).

Publication date: Jan 29, 2025

COVID-19 caused a huge backlog of patients in glaucoma clinics. This study describes redesign of an entire glaucoma service with electronic patient triage to three levels and utilisation of the Scottish optometry infrastructure of upskilled optometrists. 2276 patients in glaucoma clinics were identified and triaged to three levels in keeping with Glauc-strat-fast guidance with local amendments. Every patient detail was entered into a bespoke glaucoma database to include demographics, clinical findings and social deprivation scores. The database generated automatic patient, GP and optometrist letters. Level one patients (482) were discharged within the Scottish general optometry service contract. Level two patients (714) were discharged to glaucoma accredited community optometry clinics. The glaucoma consultants would discuss the optometry decision making through screen share once a week. Level three patients (1080) were retained in hospital. All outcomes were audited and analysed 24 months after the new service. Statistically significant parameters were found between the three groups, to include more normal eyes, less mean deviation on visual fields and less social deprivation in level one patients. After 24 months level one patients had a return rate of 40. 2%, mainly for other diseases with only 20. 4% retained within hospital or level two. 9. 4% of level two patients returned to hospital with retention of only 2. 7% in hospital at 24 months. Glaucoma patients in Scotland can be appropriately triaged to glaucoma accredited community optometry clinics. This frees capacity within hospital to see patients with moderate and severe disease in a timely fashion, for best visual outcomes.

Open Access PDF

Concepts Keywords
Diseases Adult
Fife Aged
Optometrists Aged, 80 and over
Community optometry
COVID-19
Female
Glaucoma
Glaucoma
Humans
Male
Middle Aged
Optometry
Risk stratification
SARS-CoV-2
Scotland
Triage
Triage

Semantics

Type Source Name
disease MESH glaucoma
disease MESH COVID-19
pathway REACTOME Reproduction
disease MESH blindness
drug DRUGBANK Hydroxyethyl Starch
drug DRUGBANK Trestolone
drug DRUGBANK Methionine
disease MESH allergies
disease MESH cataract
disease MESH comorbidity
disease MESH hypertension
disease MESH bronchitis
disease MESH heart disease
disease MESH cognitive decline
disease MESH living alone
disease MESH ocular hypertension
disease MESH myopia
disease MESH coma
disease MESH macular degeneration
disease MESH primary open angle glaucoma
disease MESH Normal Tension Glaucoma
drug DRUGBANK Nadide
drug DRUGBANK Coenzyme M
disease MESH treatment delays
drug DRUGBANK Serine
drug DRUGBANK Etoperidone
disease IDO process
drug DRUGBANK Hexadecanal
disease MESH eye disease
drug DRUGBANK Calcium Carbonate
drug DRUGBANK Pidolic Acid
disease IDO quality
disease MESH end of life
disease MESH Angle Closure Glaucoma

Original Article

(Visited 1 times, 1 visits today)